Radotinib
- $32 - $1600
- Product name: Radotinib
- CAS: 926037-48-1
- MF: C27H21F3N8O
- MW: 530.5
- EINECS:
- MDL Number:MFCD27956910
- Synonyms:IY5511;Radotinib;Radotinib(IY-5511);4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-(pyrazin-2-yl)pyrimidin-2-ylamino)benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phe...;Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(2-pyrazinyl)-2-pyrimidinyl]amino]-;RADOTINIB; IY5511 HCL.;IY5511 HCl.
20 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- ApexBio Technology
- Biosynth Carbosynth
- Cayman Chemical
- Chemenu
- Crysdot
- DC Chemicals
- TRC
Package
- 1mg
- 5MG
- 10mg
- 25mg
- 50mg
- 10mM(in 1mL DMSO)
- 100mg
- 250mg
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number2192CW
- Product descriptionRadotinib
- Packaging50mg
- Price$387
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0026218
- Product descriptionRADOTINIB 95.00%
- Packaging5MG
- Price$497.4
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB5846
- Product descriptionRadotinib(IY-5511)
- Packaging10mM(in 1mL DMSO)
- Price$120
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB5846
- Product descriptionRadotinib(IY-5511)
- Packaging50mg
- Price$320
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFR103403
- Product descriptionRadotinib
- Packaging25mg
- Price$150
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFR103403
- Product descriptionRadotinib
- Packaging50mg
- Price$250
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFR103403
- Product descriptionRadotinib
- Packaging100mg
- Price$330
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFR103403
- Product descriptionRadotinib
- Packaging250mg
- Price$500
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFR103403
- Product descriptionRadotinib
- Packaging500mg
- Price$900
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number19923
- Product descriptionRadotinib ≥98%
- Packaging25mg
- Price$343
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number19923
- Product descriptionRadotinib ≥98%
- Packaging10mg
- Price$184
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number19923
- Product descriptionRadotinib ≥98%
- Packaging5mg
- Price$109
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number19923
- Product descriptionRadotinib ≥98%
- Packaging1mg
- Price$32
- Updated2024-03-01
- Buy
- ManufacturerChemenu
- Product numberCM167656
- Product description4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyrazin-2-yl)pyrimidin-2-yl)amino)benzamide 98%
- Packaging100mg
- Price$524
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD31000229
- Product descriptionRadotinib 98+%
- Packaging100mg
- Price$574
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD31000229
- Product descriptionRadotinib 98+%
- Packaging50mg
- Price$431
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 2192CW | Radotinib | 50mg | $387 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | API0026218 | RADOTINIB 95.00% | 5MG | $497.4 | 2021-12-16 | Buy |
ApexBio Technology | B5846 | Radotinib(IY-5511) | 10mM(in 1mL DMSO) | $120 | 2021-12-16 | Buy |
ApexBio Technology | B5846 | Radotinib(IY-5511) | 50mg | $320 | 2021-12-16 | Buy |
Biosynth Carbosynth | FR103403 | Radotinib | 25mg | $150 | 2021-12-16 | Buy |
Biosynth Carbosynth | FR103403 | Radotinib | 50mg | $250 | 2021-12-16 | Buy |
Biosynth Carbosynth | FR103403 | Radotinib | 100mg | $330 | 2021-12-16 | Buy |
Biosynth Carbosynth | FR103403 | Radotinib | 250mg | $500 | 2021-12-16 | Buy |
Biosynth Carbosynth | FR103403 | Radotinib | 500mg | $900 | 2021-12-16 | Buy |
Cayman Chemical | 19923 | Radotinib ≥98% | 25mg | $343 | 2024-03-01 | Buy |
Cayman Chemical | 19923 | Radotinib ≥98% | 10mg | $184 | 2024-03-01 | Buy |
Cayman Chemical | 19923 | Radotinib ≥98% | 5mg | $109 | 2024-03-01 | Buy |
Cayman Chemical | 19923 | Radotinib ≥98% | 1mg | $32 | 2024-03-01 | Buy |
Chemenu | CM167656 | 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyrazin-2-yl)pyrimidin-2-yl)amino)benzamide 98% | 100mg | $524 | 2021-12-16 | Buy |
Crysdot | CD31000229 | Radotinib 98+% | 100mg | $574 | 2021-12-16 | Buy |
Crysdot | CD31000229 | Radotinib 98+% | 50mg | $431 | 2021-12-16 | Buy |
Properties
Density :1.40±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :≥26.55 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
form :solid
pka :12.94±0.70(Predicted)
color :Light yellow to yellow
storage temp. :Store at -20°C
solubility :≥26.55 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
form :solid
pka :12.94±0.70(Predicted)
color :Light yellow to yellow
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Radotinib, an inhibitor of Bcr–Abl tyrosine kinase,was approved in January 2012 in Korea as a second-line treatment for chronic myeloid leukemia (CML). Radotinib is a TKI with a similar structure to the second-generation TKI, nilotinib, in which a pyridyl group has been replaced with a pyrazinemoiety. The in vitro activity of radotinib against a variety of tumor cell lines is disclosed in an issued patent. Radotinib was significantly more potent than imatinib in all of the cell lines tested. The synthesis of radotinib via amide coupling is described in the patent literature.Related product price
- FASUDIL
$49-923 - k115 free base
$154-1290 - Rapamycin
$9-6160